Physician profile
William R Morrone
NPI 1174513766
$16,979.83
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,012 · 2020: $8,412 · 2021: $90.49 · 2022: $70.89 · 2023: $40.68 · 2024: $205 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.09 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $8,387.50 | 2020 | |
| Janssen Research & Development, LLC | $6,811.19 | 2019 | |
| Orexo US, INC. | $1,204.06 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $171.28 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Braeburn INC. | $152.91 | 2024 | Brixadi |
| Indivior INC. | $111.35 | 2019-2025 | Sublocade |
| Alkermes, INC. | $91.81 | 2019-2025 | Vivitrol, Vivitrol |
| Abbvie INC. | $49.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Morrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.